Fundraising Fox株式会社ツーセル
Hiroshima, JP · 2 known investors
Find your way into 株式会社ツーセル
Sign up to see every warm intro you have to 株式会社ツーセル
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 株式会社ツーセル team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TWOCELLS (株式会社ツーセル) is a regenerative medicine venture developing therapies and products based on mesenchymal stem cells (MSCs), including its gMSC series for cartilage regeneration, along with serum-free culture media (STK series) and consulting services. Founded as a Hiroshima University spin-off, it also licenses its technology to pharmaceutical partners.
Founders & leadership
松昌
松本 昌也代表取締役社長
Investors · 2
Frequently asked questions
- What does 株式会社ツーセル do?
- TWOCELLS (株式会社ツーセル) is a regenerative medicine venture developing therapies and products based on mesenchymal stem cells (MSCs), including its gMSC series for cartilage regeneration, along with serum-free culture media (STK series) and consulting services. Founded as a Hiroshima University spin-off, it also licenses its technology to pharmaceutical partners.
- Who are 株式会社ツーセル's investors?
- 株式会社ツーセル's investors include Hiroshima Venture Capital Co. Ltd., Shinsei Capital Partners.
- Where is 株式会社ツーセル headquartered?
- 株式会社ツーセル is headquartered in Hiroshima, JP.